Rare childhood cancers-an increasing entity requiring the need for global consensus and collaboration

Cancer Medicine

Volumn 4, Issue 6, 2015, Pages 819-824

  Kotecha, Rishi S ^a,b,c   Kees, Ursula R ^c   Cole, Catherine H ^a,b   Gottardo, Nicholas G ^a,b,c  

^a PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cancer; Childhood; Infrequent; Pediatric; Rare

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADRENAL CORTEX CARCINOMA; CANCER PROGNOSIS; CANCER REGISTRY; CANCER RESEARCH; CHILDHOOD CANCER; CONSENSUS; HEALTH CARE ORGANIZATION; HUMAN; INTERNATIONAL COOPERATION; LUNG BLASTOMA; MEDULLOBLASTOMA; NASOPHARYNX CARCINOMA; NOTE; PRIORITY JOURNAL; RARE DISEASE; TRANSLATIONAL RESEARCH; ADOLESCENT; CHILD; HEALTH; INFANT; NEOPLASMS; NEWBORN; PRESCHOOL CHILD; PREVALENCE; RARE DISEASES; REGISTER;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CONSENSUS; GLOBAL HEALTH; HUMANS; INFANT; INFANT, NEWBORN; INTERNATIONAL COOPERATION; NEOPLASMS; PREVALENCE; RARE DISEASES; REGISTRIES;

EID: 85006226891     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.426     Document Type: Note

References (44)

1. Howlader, N., A. M. Noone, M. Krapcho, J. Garshell, D. Miller, S. F. Altekruse, et al. (eds.). 2014. SEER cancer statistics review, 1975-2011. National Cancer Institute, Bethesda, MD. Available at http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
2. Kaatsch, P. 2010. Epidemiology of childhood cancer. Cancer Treat. Rev. 36:277-285.
3. Baade, P. D., D. R. Youlden, P. C. Valery, T. Hassall, L. Ward, A. C. Green, and J. F. Aitken . 2010. Trends in incidence of childhood cancer in Australia, 1983-2006. Br. J. Cancer 102:620-626.
4. Pashankar, F. D., C. Rodriguez-Galindo, and A. Pappo . 2012. Development of a therapeutic approach to rare cancers in children: the Children's Oncology Group experience. J. Pediatr. Hematol. Oncol. 34(Suppl. 2):S37-S38.
5. Steliarova-Foucher, E., C. Stiller, B. Lacour, and P. Kaatsch . 2005. International Classification of Childhood Cancer, third edition. Cancer 103:1457-1467.
6. Ribeiro, R. C., F. Sandrini, B. Figueiredo, G. P. Zambetti, E. Michalkiewicz, A. R. Lafferty, et al. 2001. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc. Natl. Acad. Sci. USA 98:9330-9335.
7. Hill, D. A., J. Ivanovich, J. R. Priest, C. A. Gurnett, L. P. Dehner, D. Desruisseau, et al. 2009. DICER1 mutations in familial pleuropulmonary blastoma. Science 325:965.
8. Schultze-Florey, R. E., N. Graf, P. Vorwerk, E. Koscielniak, D. T. Schneider, and C. P. Kratz . 2013. DICER1 syndrome: a new cancer syndrome. Klin. Padiatr. 225:177-178.
9. Reynoird, N., B. E. Schwartz, M. Delvecchio, K. Sadoul, D. Meyers, C. Mukherjee, et al. 2010. Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains. EMBO J. 29:2943-2952.
10. Schwartz, B. E., M. D. Hofer, M. E. Lemieux, D. E. Bauer, M. J. Cameron, N. H. West, et al. 2011. Differentiation of NUT midline carcinoma by epigenomic reprogramming. Cancer Res. 71:2686-2696.
11. Grayson, A. R., E. M. Walsh, M. J. Cameron, J. Godec, T. Ashworth, J. M. Ambrose, et al. 2014. MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma. Oncogene 33:1736-1742.
12. Michalkiewicz, E., R. Sandrini, B. Figueiredo, E. C. Miranda, E. Caran, A. G. Oliveira-Filho, et al. 2004. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. J. Clin. Oncol. 22:838-845.
13. Priest, J. R., D. A. Hill, G. M. Williams, C. L. Moertel, Y. Messinger, M. J. Finkelstein, et al. 2006. Type I pleuropulmonary blastoma: a report from the International Pleuropulmonary Blastoma Registry. J. Clin. Oncol. 24:4492-4498.
14. Messinger, Y. H., D. R. Stewart, J. R. Priest, G. M. Williams, A. K. Harris, K. A. Schultz, et al. 2015. Pleuropulmonary blastoma: a report on 350 central pathology-confirmed pleuropulmonary blastoma cases by the International Pleuropulmonary Blastoma Registry. Cancer 121:276-285.
15. Bauer, D. E., C. M. Mitchell, K. M. Strait, C. S. Lathan, E. B. Stelow, S. C. Lüer, et al. 2012. Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin. Cancer Res. 18:5773-5779.
16. Ross, J. H., L. Rybicki, and R. Kay . 2002. Clinical behavior and a contemporary management algorithm for prepubertal testis tumors: a summary of the Prepubertal Testis Tumor Registry. J. Urol. 168:1675-1678; discussion 1678-1679.
17. Janeway, K. A., S. Y. Kim, M. Lodish, V. Nosé, P. Rustin, J. Gaal, et al. 2011. Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations. Proc. Natl. Acad. Sci. USA 108:314-318.
18. Kelly, L., K. Bryan, S. Y. Kim, K. A. Janeway, J. K. Killian, H. U. Schildhaus, et al. 2013. Post-transcriptional dysregulation by miRNAs is implicated in the pathogenesis of gastrointestinal stromal tumor [GIST]. PLoS One 8:e64102.
19. Killian, J. K., S. Y. Kim, M. Miettinen, C. Smith, M. Merino, M. Tsokos, et al. 2013. Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov. 3:648-657.
20. Rodriguez-Galindo, C., M. Krailo, L. Frazier, M. Chintagumpala, J. Amatruda, H. Katzenstein, et al. 2013. Children's Oncology Group's 2013 blueprint for research: rare tumors. Pediatr. Blood Cancer 60:1016-1021.
21. Pappo, A. S., M. Krailo, Z. Chen, C. Rodriguez-Galindo, and G. Reaman . 2010. Infrequent tumor initiative of the Children's Oncology Group: initial lessons learned and their impact on future plans. J. Clin. Oncol. 28:5011-5016.
22. Rapkin, L., and F. D. Pashankar . 2012. Management of thyroid carcinoma in children and young adults. J. Pediatr. Hematol. Oncol. 34(Suppl. 2):S39-S46.
23. Goldberg, J., and W. L. Furman . 2012. Management of colorectal carcinoma in children and young adults. J. Pediatr. Hematol. Oncol. 34(Suppl. 2):S76-S79.
24. Neier, M., A. Pappo, and F. Navid . 2012. Management of melanomas in children and young adults. J. Pediatr. Hematol. Oncol. 34(Suppl. 2):S51-S54.
25. Janeway, K. A., and A. Pappo . 2012. Treatment guidelines for gastrointestinal stromal tumors in children and young adults. J. Pediatr. Hematol. Oncol. 34(Suppl. 2):S69-S72.
26. Glick, R. D., F. D. Pashankar, A. Pappo, and M. P. Laquaglia . 2012. Management of pancreatoblastoma in children and young adults. J. Pediatr. Hematol. Oncol. 34(Suppl. 2):S47-S50.
27. Jordan, A. H., and A. Pappo . 2012. Management of desmoplastic small round-cell tumors in children and young adults. J. Pediatr. Hematol. Oncol. 34(Suppl. 2):S73-S75.
28. Schultz, K. A., D. T. Schneider, F. Pashankar, J. Ross, and L. Frazier . 2012. Management of ovarian and testicular sex cord-stromal tumors in children and adolescents. J. Pediatr. Hematol. Oncol. 34(Suppl. 2):S55-S63.
29. Howell, D. L., and M. S. O'Dorisio . 2012. Management of neuroendocrine tumors in children, adolescents, and young adults. J. Pediatr. Hematol. Oncol. 34(Suppl. 2):S64-S68.
30. Ferrari, A., G. Bisogno, G. L. De Salvo, P. Indolfi, G. Perilongo, and G. Cecchetto . 2007. The challenge of very rare tumours in childhood: the Italian TREP project. Eur. J. Cancer 43:654-659.
31. Brecht, I. B., N. Graf, D. V. Schweinitz, M. C. Frühwald, S. S. Bielack, and D. T. Schneider . 2009. Networking for children and adolescents with very rare tumors: foundation of the GPOH Pediatric Rare Tumor Group. Klin. Padiatr. 221:181-185.
32. Bisogno, G., A. Ferrari, E. Bien, I. B. Brecht, B. Brennan, G. Cecchetto, et al. 2012. Rare cancers in children-The EXPeRT Initiative: a report from the European Cooperative Study Group on Pediatric Rare Tumors. Klin. Padiatr. 224:416-420.
33. Bien, E., J. Godzinski, P. Dall'igna, A. S. Defachelles, T. Stachowicz-Stencel, D. Orbach, et al. 2011. Pancreatoblastoma: a report from the European Cooperative Study Group for Paediatric Rare Tumours (EXPeRT). Eur. J. Cancer 47:2347-2352.
34. Bisogno, G., B. Brennan, D. Orbach, T. Stachowicz-Stencel, G. Cecchetto, P. Indolfi, et al. 2014. Treatment and prognostic factors in pleuropulmonary blastoma: an EXPeRT report. Eur. J. Cancer 50:178-184.
35. Schneider, D. T., D. Orbach, G. Cecchetto, T. Stachowicz-Stencel, B. Brummel, I. B. Brecht, et al. 2014. Ovarian Sertoli Leydig cell tumours in children and adolescents: an analysis of the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT). Eur. J. Cancer. doi: 10.1016/j.ejca.2014.11.013
36. Gajjar, A., S. M. Pfister, M. D. Taylor, and R. J. Gilbertson . 2014. Molecular insights into pediatric brain tumors have the potential to transform therapy. Clin. Cancer Res. 20:5630-5640.
37. Roberts, K. G., Y. Li, D. Payne-Turner, R. C. Harvey, Y. L. Yang, D. Pei, et al. 2014. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N. Engl. J. Med. 371:1005-1015.
38. Shih, D. J., P. A. Northcott, M. Remke, A. Korshunov, V. Ramaswamy, M. Kool, et al. 2014. Cytogenetic prognostication within medulloblastoma subgroups. J. Clin. Oncol. 32:886-896.
39. Kool, M., D. T. Jones, N. Jäger, P. A. Northcott, T. J. Pugh, V. Hovestadt, et al. 2014. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell 25:393-405.
40. Frazier, A. L., J. P. Hale, C. Rodriguez-Galindo, H. Dang, T. Olson, M. J. Murray, et al. 2015. Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States. J. Clin. Oncol. 33:195-201.
41. Kotecha, R. S., E. M. Pascoe, E. J. Rushing, L. B. Rorke-Adams, T. Zwerdling, X. Gao, et al. 2011. Meningiomas in children and adolescents: a meta-analysis of individual patient data. Lancet Oncol. 12:1229-1239.
42. Gottardo, N. G., J. R. Hansford, J. P. McGlade, F. Alvaro, D. M. Ashley, S. Bailey, et al. 2014. Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group. Acta Neuropathol. 127:189-201.
43. Biondi, A., A. Baruchel, S. Hunger, G. Masera, K. Schmiegelow, M. Schrappe, and C. H. Pui . 2009. The Eleventh International Childhood Acute Lymphoblastic Leukemia Workshop Report: Ponte di Legno, Italy, 6-7 May 2009. Leukemia 23:2318-2324.
44. Sastre, X., G. L. Chantada, F. Doz, M. W. Wilson, M. T. de Davila, C. Rodriguez-Galindo, et al. 2009. Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch. Pathol. Lab. Med. 133:1199-1202.